Howland Capital Management LLC Pfizer Inc Transaction History

Howland Capital Management LLC

$2.26 Billion
Q3 2024

A detailed history of Howland Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Howland Capital Management LLC holds 59,337 shares of PFE stock, worth $1.59 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

59,337

Previous 61,744 3.9%

Holding current value

$1.59 Million

Previous $1.73 Million 0.58%

% of portfolio

0.08%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $66,673 - $75,555	-2,407 Reduced 3.9%	59,337 $1.72 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $35,288 - $41,351	-1,397 Reduced 2.21%	61,744 $1.73 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $127,663 - $146,598	-4,931 Reduced 7.24%	63,141 $1.75 Million
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $111,000 - $144,177	-4,248 Reduced 5.87%	68,072 $1.96 Million
Q3 2023 Oct 17, 2023	SELL	$32.09 - $37.51 $69,795 - $81,584	-2,175 Reduced 2.92%	72,320 $2.4 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $16,723 - $19,348	-463 Reduced 0.62%	74,495 $2.73 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $207,545 - $270,194	-5,269 Reduced 6.57%	74,958 $3.06 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $70,975 - $92,650	1,700 Added 2.16%	80,227 $4.11 Million
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $211,492 - $258,178	4,833 Added 6.56%	78,527 $3.44 Million
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $550,031 - $652,164	11,821 Added 19.11%	73,694 $3.86 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $101,244 - $125,454	2,213 Added 3.71%	61,873 $3.2 Million
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $6,611 - $9,800	160 Added 0.27%	59,660 $3.52 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $23,942 - $30,756	-610 Reduced 1.01%	59,500 $2.56 Million
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $71,460 - $80,953	-1,990 Reduced 3.2%	60,110 $2.35 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $122,774 - $138,464	3,666 Added 6.27%	62,100 $2.25 Million
Q4 2020 Jan 26, 2021	SELL	$33.47 - $42.56 $7,463 - $9,490	-223 Reduced 0.38%	58,434 $2.15 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $14,287 - $16,762	-450 Reduced 0.76%	58,657 $2.15 Million
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $21,204 - $25,724	-704 Reduced 1.18%	59,107 $1.93 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $48,654 - $69,516	1,800 Added 3.1%	59,811 $1.95 Million
Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $151,259 - $216,117	-5,596 Reduced 8.8%	58,011 $1.8 Million
Q4 2019 Jan 23, 2020	SELL	$32.92 - $37.36 $117,030 - $132,814	-3,555 Reduced 5.29%	63,607 $2.49 Million
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $177,687 - $230,408	5,469 Added 8.86%	67,162 $2.41 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $110,237 - $123,771	-2,981 Reduced 4.61%	61,693 $2.67 Million
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $228,300 - $250,825	-6,088 Reduced 8.6%	64,674 $2.75 Million
Q4 2018 Jan 23, 2019	SELL	$38.47 - $43.86 $190,849 - $217,589	-4,961 Reduced 6.55%	70,762 $3.09 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $4,412 - $5,351	-128 Reduced 0.17%	75,723 $3.34 Million
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $37,597 - $40,082	-1,140 Reduced 1.48%	75,851 $2.75 Million
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $95,666 - $110,985	-2,998 Reduced 3.75%	76,991 $2.73 Million
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $3,326 - $3,529	-100 Reduced 0.12%	79,989 $2.9 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $2.48 Million - $2.74 Million	80,089	80,089 $2.86 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Pfizer Inc Transaction History